Unknown OBSERVATIONAL NCT03818100

Neo-RT: A Study Investigating Whether Changing the Sequence of Treatments (Starting Radiotherapy Followed by Hormone Therapy Before Surgery) is Feasible (Neo-RT)

Neo-RT: Pre-operative Breast Intensity Modulated Radiotherapy in Patients Receiving Neo-adjuvant Hormonal Treatment for Breast Cancer - a Feasibility Study.

Sponsor: Breast Cancer Now

Conditions Breast Cancer

Interventions Breast conserving surgery Endocrine therapy Intensity modulated radiotherapy (IMRT)

Updated 8 times since 2019 Last updated: Jul 26, 2021 Started: Mar 26, 2018 Primary completion: Apr 30, 2022 Completion: Dec 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Breast Cancer and is currently ongoing. Breast Cancer Now leads this study, which shows 8 recorded versions since 2018 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Aug 2023 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Dec 2021 — Aug 2023 [monthly]

Recruiting
Sep 2021 — Dec 2021 [monthly]

Recruiting

▶ Show 3 earlier versions

Jan 2021 — Sep 2021 [monthly]

Recruiting
Nov 2020 — Jan 2021 [monthly]

Recruiting
Feb 2019 — Nov 2020 [monthly]

Recruiting

First recorded

Mar 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Breast Cancer Now
CCTU- Cancer Theme
CRUK Cambridge Institute

Data source: Cambridge University Hospitals NHS Foundation Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cambridge, United Kingdom